Piracetam
Synthetic nootropic studied for age-related cognitive decline and memory, with mixed clinical results and unapproved supplement status in the US.
Our methodology: How we evaluate supplements and turn the underlying research into a single rating.
This supplement may interact with medications, medical conditions or sensitive populations. Review safety before use.
Skip for healthy adults; weak evidence for cognitive enhancement and not approved as a dietary supplement in the US.
Piracetam is a synthetic GABA-derived compound developed in the 1960s as the prototypical nootropic; it does not occur in food. It is thought to modulate AMPA-receptor neurotransmission and improve neuronal membrane fluidity. Clinical trials show inconsistent, modest benefits for age-related cognitive decline and post-stroke aphasia, while evidence for memory enhancement in healthy adults remains weak. It is most often considered by older adults with mild cognitive impairment, though it is not approved as a dietary supplement in the United States.
Potential benefits
Protocol
Onset Time
Who Should Consider
How It Works
Piracetam positively allosterically modulates AMPA receptors, facilitating cholinergic neurotransmission. It also appears to increase membrane fluidity in erythrocytes and neurons and may enhance mitochondrial function and cerebral glucose metabolism without direct sedative or stimulant activity.
Put Piracetam in context.
Compare the closest evidence-ranked options, or see how this supplement fits your goals and what you already take.
Is Piracetam right for your goals?
Answer four quick questions for recommendations that already account for the supplement you just reviewed.
Keep comparing
Related options by shared goals, evidence, and verified pairings.